Drug Trial Radar · NCT06955741
A Study to Assess Drug Levels, Tolerability and Absolute Biological Availability of Single-dose of BMS-986446 in Healthy Participants
Last checked: Nov 19, 2026Latest source record: Oct 1, 2025 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
46
Actual
Start
May 5, 2025
Primary completion
Sep 11, 2025
Study completion Sep 11, 2025
Sponsor
- Lead sponsor
- Bristol-Myers SquibbBristol Myers Squibb (BMY)
- Sponsor type
- Industry
- First posted
- May 2, 2025
Design
- Study type
- Interventional
- Phase
- Phase 1
- Allocation
- Randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years, up to 65 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
The purpose of this study is to assess drug levels, tolerability and absolute biological availability of single subcutaneous dose of BMS-986446 in healthy participants
Conditions
- Healthy Volunteer
Interventions
BMS-986446 IVDrug
Specified dose on specified days was administered intravenously (IV).
BMS-986446 SCDrug
Specified dose on specified days was administered subcutaneously (SC).
AcetaminophenDrug
Specified dose on specified days
LoratadineDrug
Specified dose on specified days
Primary outcomes
What the sponsor says the trial is designed to measure.
- Geometric Mean Ratio (GMR) of Maximum Observed Serum Concentration (Cmax) of BMS-986446 Administered IV versus SCTime frame: Up to approximately Day 85
- GMR of Area Under the Serum Concentration-time Curve From Time Zero to Time of Last Quantifiable Concentration (AUC(0-T)) of BMS-986446 Administered IV versus SCTime frame: Up to approximately Day 85
- GMR of Area Under the Serum Concentration-time Curve From Time Zero to 672 Hours (AUC(0-672)) of BMS-986446 Administered IV versus SCTime frame: Up to approximately Day 85
- Absolute Bioavailability (F) Estimated From GMR of AUC(INF) of BMS-986446 Administered as SC versus IV InfusionTime frame: Up to approximately Day 85
Locations
2 sites in 1 country. Site status is shown where the registry gives one.
Local Institution - 0001
Anaheim, California
Local Institution - 10000
Anaheim, California
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.